您的位置: 首页 > 农业专利 > 详情页

Targeting interferon-lambda with antibodies potently enhances anti-tumor and anti-viral activities
专利权人:
Inc.;IBC Pharmaceuticals
发明人:
Chang, Chien-Hsing,Goldenberg, David M.,Liu, Donglin
申请号:
AU2013212000
公开号:
AU2013212000A1
申请日:
2013.01.25
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The present invention concerns methods and compositions for forming complexes of interferon-λ with an antibody or antigen-binding antibody fragment. In preferred embodiments, the interferon-λ and the antibody or fragment are fusion proteins, each comprising a dimerization and docking domain (DDD) moiety from human protein kinase A or an anchor domain (AD) moiety from an A-kinase anchoring protein (AKAP). In more preferred embodiments, the interferon-antibody complex is more efficacious for treatment of cancer, asthma, Alzheimer's disease, multiple sclerosis or viral infection than interferon-λ alone, antibody alone, or the combination of unconjugated interferon-λ and antibody.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充